Uctepe Eyyup, Mancılar Hanifenur, Esen Fatma Nisa, Unverengil Gokcen Gundogdu, Vona Barbara, Yesilyurt Ahmet
Acibadem Labgen Genetic Diagnosis Center, Istanbul, Türkiye.
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
Am J Med Genet A. 2025 Apr;197(4):e63952. doi: 10.1002/ajmg.a.63952. Epub 2024 Dec 17.
Rhabdomyolysis is a severe condition involving the breakdown of skeletal muscle fibers, leading to the release of muscle components into the bloodstream, which can lead to potential complications such as acute kidney injury and electrolyte imbalances. The etiology of rhabdomyolysis is multifactorial, encompassing traumatic, exertional, metabolic, infectious, toxic, and genetic causes. Genetic causes, including variants in LPIN1, RYR1, and CACNA1S, are increasingly recognized as significant contributors to recurrent rhabdomyolysis. MYH1 has recently been identified as a candidate gene for recurrent rhabdomyolysis with limited evidence originating from a single patient. In this report, we describe a 35-year-old male, born to consanguineous parents, who presented with recurrent rhabdomyolysis attacks, beginning at age 28, characterized by muscle pain, weakness, and episodes of acute kidney injury requiring dialysis. During attacks, the patient exhibited remarkably elevated markers of muscle breakdown and mildly elevated creatine kinase levels between episodes. A muscle biopsy revealed non-specific myopathic changes. Exome sequencing analysis was carried out and revealed a novel homozygous variant (NM_005963.4: c.1825G>A [p.Val609Met]) in MYH1 segregating in a manner compatible with an autosomal recessive pattern. In summary, this case provides confirmatory support for the role of pathogenic MYH1 variants in the pathogenesis of recurrent rhabdomyolysis and emphasizes the importance of comprehensive genetic testing in patients with unexplained recurrent episodes of muscle breakdown. Further cases are necessary to fully elucidate the genotypic and phenotypic spectrum of MYH1-related muscle disorders.
横纹肌溶解症是一种严重病症,涉及骨骼肌纤维的分解,导致肌肉成分释放到血液中,这可能引发诸如急性肾损伤和电解质失衡等潜在并发症。横纹肌溶解症的病因是多因素的,包括创伤性、运动性、代谢性、感染性、中毒性和遗传性病因。包括LPIN1、RYR1和CACNA1S基因变异在内的遗传病因,越来越被认为是复发性横纹肌溶解症的重要促成因素。MYH1最近被确定为复发性横纹肌溶解症的候选基因,但仅有来自一名患者的有限证据。在本报告中,我们描述了一名35岁男性,其父母为近亲结婚,自28岁起出现复发性横纹肌溶解症发作,表现为肌肉疼痛、无力以及需要透析的急性肾损伤发作。发作期间,患者肌肉分解标志物显著升高,发作间期肌酸激酶水平轻度升高。肌肉活检显示非特异性肌病改变。进行了外显子组测序分析,结果显示MYH1基因存在一种新的纯合变异(NM_005963.4: c.1825G>A [p.Val609Met]),其分离方式符合常染色体隐性模式。总之,本病例为致病性MYH1变异在复发性横纹肌溶解症发病机制中的作用提供了确证支持,并强调了对不明原因复发性肌肉分解患者进行全面基因检测的重要性。需要更多病例来充分阐明MYH1相关肌肉疾病的基因型和表型谱。